Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Kaori Hamamoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5076362077. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. A Novel Index Consisting of Age, CA19-9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer. Co-author DOI 10.1002/cam4.72202↗
  2. High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation. Co-author DOI 10.1038/s41598-026-56838-2↗
  3. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000527342↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taro Takami · 3 shared papers, 2022–2026 · strength 0.66
  2. Shigeyuki Suenaga · 3 shared papers, 2022–2026 · strength 0.66
  3. Shuhei Shinoda · 2 shared papers, 2026 · strength 0.55
  4. Yutaka Suehiro · 2 shared papers, 2022–2026 · strength 0.37
  5. Takahiro Yamasaki · 2 shared papers, 2022–2026 · strength 0.37
  6. Shin Hamada · 1 shared paper, 2026 · strength 0.29
  7. Atsushi Masamune · 1 shared paper, 2026 · strength 0.29
  8. Masato Yamamoto · 1 shared paper, 2026 · strength 0.29
  9. Shoko Tabara · 1 shared paper, 2026 · strength 0.26
  10. Yuko Fujimoto · 1 shared paper, 2022 · strength 0.12
  11. Shogo Amano · 1 shared paper, 2022 · strength 0.12
  12. Hiroaki Nagano · 1 shared paper, 2022 · strength 0.12
  13. Keiko Shinjo · 1 shared paper, 2022 · strength 0.12
  14. Isao Sakaida · 1 shared paper, 2022 · strength 0.12
  15. Hiroto Matsui · 1 shared paper, 2022 · strength 0.12
  16. Yutaka Kondo · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.